Preactivity CaseLink
0.5 CME/CE Credits

Prepare for the November 19 live event at your convenience with this on-demand Web activity. Work on your own to determine what the right course of action would be for this case study patient with schizophrenia. This program will update clinicians on the latest evidence base and clinical guidelines regarding maintenance therapy, with the goal of increasing the likelihood of full remission and significantly reducing patient relapse rates. Studying the case in the preactivity in advance of the broadcast will enhance your understanding of the challenges this patient presents, and the reasoning behind the treatment options that the faculty will discuss.

Upon completion of this activity, participants should be able to:

• Communicate effectively with patients regarding the need for and duration of maintenance-phase treatment.

John Kane, MD
Chairman, Department of Psychiatry
The Zucker Hillside Hospital;
Professor of Psychiatry, Neurology, and Neuroscience
Albert Einstein College of Medicine

It is the policy of The Chatham Institute to ensure balance, independence, objectivity, and scientific rigor in all of its educational programs. All faculty, planners, and managers who affect the content of medical education activities sponsored by The Chatham Institute are required to disclose to the audience any real or apparent conflict of interest related to the activity. Faculty, planners, and managers not complying with the disclosure policy will not be permitted to participate in this activity. Independent peer reviewers have nothing to disclose. Disclosure information is provided below.

John Kane, MD
Dr. Kane is a consultant for Bristol-Myers Squibb Company, Cephalon, Inc., Eli Lilly and Company, Lundbeck Pharmaceuticals, Ortho-McNeil-Janssen Pharmaceuticals, Inc., Pfizer Inc, and Wyeth Pharmaceuticals, and is on the speaker bureaus of AstraZeneca Pharmaceuticals, Bristol-Myers Squibb Company, Eli Lilly and Company, and Ortho-McNeil-Janssen Pharmaceuticals, Inc.

Bagirathy Ravishankar, PhD
Scientific Director, The Chatham Institute
No real or apparent relationships to disclose.

CE/CME Credit Instructions and Accreditation Information:
Successful completion of this CE/CME activity includes the following:

• Viewing the presentation and reviewing the course materials
• Completing the appropriate CE/CME application and activity evaluation form online
• Scoring 70% or above on the posttest

Participants may print a statement of credit online after successful completion of the activity. There is no fee for participating in this activity.

Physicians: The Chatham Institute is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The Chatham Institute designates this educational activity for a maximum of 0.5 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Nurses: The Chatham Institute LLC is an approved provider of continuing nursing education by the New Jersey State Nurses Association (NJSNA), an accredited approver by the American Nurses Credentialing Center's (ANCC's) Commission on Accreditation, provider number P175-11/2006-2009.

The Chatham Institute LLC is approved by the California Board of Registered Nursing (CBRN), provider number CEP 12433.

This activity is approved for 0.5 contact hours.

Disclaimer: Accreditation refers to educational content only and does not imply endorsement of products by NJSNA, ANCC, CBRN, or The Chatham Institute LLC.

This activity is sponsored by The Chatham Institute and supported by an educational grant from Ortho-McNeil-Janssen Scientific Affairs, LLC.